共 50 条
- [21] Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study designFUTURE ONCOLOGY, 2022, 18 (14) : 1669 - 1678Bourhis, JeanBurtness, BarbaraLicitra, Lisa F.Nutting, ChristopherSchoenfeld, Jonathan D.Omar, MokhtarBouisset, FlorileneNauwelaerts, HeidiUrfer, YuliaZanna, ClaudioCohen, Ezra Ew
- [23] Retrospective study of cisplatin plus radiotherapy toxicities in locally advanced squamous cell carcinoma of the head and neck - ReCisTT studyFRONTIERS IN ONCOLOGY, 2024, 14Gomes, Ana VargesCastro Jr, Gilbertode Oliveira, Thiago BuenoColmenero, Ana MedinaRibeiro, LeonorPsyrri, AmandaMagne, NicolasPlana Serrahima, MariaMarinho, JoanaGiglio, RaulIglesias Rey, LeticiaAngel, MartinMacedo, Ana M.
- [24] Induction Chemotherapy with Cisplatin, Paclitaxel, and Capecitabine (PTC) in Locally Advanced (LA) Squamous Cell Carcinoma of Head and Neck (SCCHN)INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (05): : E26 - E26Alvarado-Munoz, J. F.Reyes-Morales, A.Puac-Polanco, V.Bruixola, G.Chivalan, M.Torselli, S.
- [25] Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trialEUROPEAN JOURNAL OF CANCER, 2023, 183 : 24 - 37Tao, YunganSun, Xu-ShanPointreau, YoannLe Tourneau, ChristopheSire, ChristianKaminsky, Marie-ChristineCoutte, AlexandreAlfonsi, MarcCalderon, BenoitBoisselier, PierreMartin, LaurentMiroir, JessicaRamee, Jean-FrancoisDelord, Jean-PierreClatot, FlorianRolland, FredericVilla, JulieMagne, NicolasElicin, OlgunGherga, ElisabetaNguyen, FranceLafond, CedrikBera, GuillaumeCalugaru, ValentinGeoffrois, LionnelChauffert, BrunoDamstrup, LarsCrompton, PhilippaEnnaji, AbdallahGollmer, KathrinNauwelaerts, HeidiBourhis, Jean
- [26] PHASE I/II STUDY OF ERLOTINIB COMBINED WITH CISPLATIN AND RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECKINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : 696 - 702Herchenhorn, DanielDias, Fernando L.Viegas, Celia M. P.Federico, Miriam H.Araujo, Carlos Manoel M.Small, IsabelleBezerra, MarcosFontao, KarinaKnust, Renata E.Ferreira, Carlos G.Martins, Renato G.
- [27] Nivolumab (Nivo) and ipilimumab (Ipi) combined with radiotherapy (RT) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN): Updated results of a pilot studyANNALS OF ONCOLOGY, 2021, 32 : S791 - S791Johnson, J. M.Ali, A.Lorber, E.Poller, D.Keith, S. W.Luginbuhl, A.Curry, J. M.Cognetti, D.Axelrod, R.Bar-Ad, V.Argiris, A.
- [28] A phase I, open-label study of lapatinib plus chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 293S - 293SHarrington, K. J.Bourhis, J.Nutting, C. M.Rosine, D.Theodosiou, A. M.Gardiner, S.Berger, M. S.Beelen, A. P.Stead, A. G.El-Hariry, I. A.
- [29] PROGNOSTIC SIGNIFICANCE OF P16 IN LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (LA-SCCHN) TREATED WITH CONCURRENT CISPLATIN AND RADIOTHERAPYRADIOTHERAPY AND ONCOLOGY, 2008, 88 : S141 - S141Lau, H.Hao, D.Eliasziw, M.Lees-Miller, S.Magliocco, A.
- [30] PHASE I STUDY OF CONCURRENT PEMETREXED, CETUXIMAB AND RADIATION THERAPY WITH OR WITHOUT CISPLATIN IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)ANNALS OF ONCOLOGY, 2010, 21 : 320 - 320Licitra, L.Bergamini, C.Olmi, P.Soldatenkova, V.Ameryckx, S.Russo, F.